Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: jpbrody who wrote (2973)	6/12/1998 12:44:00 AM
From: Quad Sevens	Read Replies (2) \| Respond to of 5736

jp: I'm going going with Maisel's 16 million tests in the U.S. That triples it. Then you've got the rest of the health-care affluent world; triples it again. CCSI's device is superior to SPRX's: all races, phototherapy, etc. (BTW: What does SPRX say about its correlation with actual serum bilirubin? We got 95% with CCSI, says FDA. CCSI can charge more since it is FDA approved. Or is H & Q assuming FDA approval at some point?) More tests will be done because it's non-invasive. << I also think they will have a hard time keeping the disposable proprietary. Historically high margin (razor blade type) things bring about a secondary market. It happens with laser printer cartridges, razor blades, and I know it even happens with test reagents used in hospitals. >> Well, you're not going to get sued by angry parents for using the wrong laser-printer cartridge. Leica says this about their bilirubinometer: ''only Leica catalog number 10214 disposable cuvettes may be used with the Unistat bilirubinometer. 10214 cuvettes are for one-time use only and are never to be reused." Looks bad in court when baby dies and you didn't follow the manual. I guess a cuvette is a small cuve with a feminine aspect. Wade